# A Study of Injection HB002.1T in Subjects With Solid Tumor

> **NCT03636750** · PHASE1 · COMPLETED · sponsor: **Huabo Biopharm Co., Ltd.** · enrollment: 27 (actual)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** HB002.1T

## Key facts

- **NCT ID:** NCT03636750
- **Lead sponsor:** Huabo Biopharm Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-28
- **Primary completion:** 2020-02-20
- **Final completion:** 2020-03-21
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2021-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03636750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03636750, "A Study of Injection HB002.1T in Subjects With Solid Tumor". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03636750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*